欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/V/0422/001
药品名称Program 40 mg Suspension for Injection for Cats
活性成分
    • lufenuron 10.0 %w/v
剂型Suspension for injection
上市许可持有人Elanco GmbH Heinz-Lohmann-Str. 4 27472 Cuxhaven Germany
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
      Program 40 (Injectable suspension for cats)
    • Denmark (DK)
      Program 40 (Injectable suspension for cats)
    • Belgium (BE)
      Program 40 (Injectable suspension for cats)
    • Luxembourg (LU)
      Program 40 (Injectable suspension for cats)
    • Austria (AT)
      Program 40 (Injectable suspension for cats)
    • Portugal (PT)
      Program 40 (Injectable suspension for cats)
    • France (FR)
许可日期2008/04/05
最近更新日期2023/12/05
药物ATC编码
    • QP53BX Other ectoparasiticides for systemic use
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase